問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
余忠仁
下載
2025-11-01 - 2033-12-31
Condition/Disease
Locally advanced unresectable or metastatic HER2-overexpressing non-squamous non-small cell lung cancer
Test Drug
Trastuzumab Deruxtecan(AZD4552 DS-8201A)
Participate Sites9Sites
Recruiting9Sites
2018-12-01 - 2027-12-31
Participate Sites4Sites
Recruiting4Sites
Division of Hematology & Oncology
2021-04-01 - 2033-02-28
2025-08-01 - 2031-12-31
Participate Sites7Sites
Recruiting7Sites
2024-01-01 - 2040-12-31
2020-02-01 - 2025-12-10
Participate Sites8Sites
Recruiting5Sites
Terminated3Sites
2020-10-01 - 2026-01-08
Participate Sites3Sites
Not yet recruiting1Sites
Recruiting2Sites
2020-01-01 - 2026-12-31
Participate Sites5Sites
2020-07-01 - 2022-05-01
Participate Sites2Sites
2020-04-01 - 2025-01-31
Terminated2Sites
全部
